07/26/2024 3:15 PM | 60 Degrees Pharmaceuticals (Filer) 60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/26/2024 12:21 PM | 60 Degrees Pharmaceuticals (Filer) 60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 424B5 | |
07/24/2024 4:05 PM | 60 Degrees Pharmaceuticals (Filer) 60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 424B5 | |
07/22/2024 10:23 AM | 60 Degrees Pharmaceuticals (Filer) 60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 424B5 | |
07/18/2024 11:15 PM | 60 Degrees Pharmaceuticals (Filer) 60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form EFFECT | |
07/16/2024 4:28 PM | 60 Degrees Pharmaceuticals (Filer) 60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/12/2024 4:02 PM | 60 Degrees Pharmaceuticals (Filer) 60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
|
07/09/2024 2:37 PM | 60 Degrees Pharmaceuticals (Filer) 60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/27/2024 4:06 PM | 60 Degrees Pharmaceuticals (Filer) 60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/12/2024 4:26 PM | 60 Degrees Pharmaceuticals (Filer) 60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/30/2024 1:15 PM | 60 Degrees Pharmaceuticals (Filer) 60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form DEF 14A | |
05/21/2024 7:22 PM | 60 Degrees Pharmaceuticals (Issuer) 60 DEGREES PHARMACEUTICALS, INC. (Issuer) MILLER TYRONE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 7:23 PM | 60 Degrees Pharmaceuticals (Issuer) 60 DEGREES PHARMACEUTICALS, INC. (Issuer) TOOVEY STEPHEN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 7:23 PM | 60 Degrees Pharmaceuticals (Issuer) 60 DEGREES PHARMACEUTICALS, INC. (Issuer) XU CHERYL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 7:18 PM | 60 Degrees Pharmaceuticals (Issuer) 60 DEGREES PHARMACEUTICALS, INC. (Issuer) Allen Charles W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 7:19 PM | 60 Degrees Pharmaceuticals (Issuer) 60 DEGREES PHARMACEUTICALS, INC. (Issuer) DOW GEOFFREY S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 7:20 PM | 60 Degrees Pharmaceuticals (Issuer) 60 DEGREES PHARMACEUTICALS, INC. (Issuer) FIELD PAUL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 10:56 AM | 60 Degrees Pharmaceuticals (Filer) 60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024 6:19 PM | 60 Degrees Pharmaceuticals (Subject) 60 DEGREES PHARMACEUTICALS, INC. (Subject) KNIGHT THERAPEUTICS INTERNATIONAL SA (Filed by)
| Form SC 13G/A | |
04/03/2024 5:00 PM | 60 Degrees Pharmaceuticals (Issuer) 60 DEGREES PHARMACEUTICALS, INC. (Issuer) Knight Therapeutics Inc (Reporting) KNIGHT THERAPEUTICS INTERNATIONAL SA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2024 1:32 PM | 60 Degrees Pharmaceuticals (Filer) 60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/02/2024 2:31 PM | 60 Degrees Pharmaceuticals (Issuer) 60 DEGREES PHARMACEUTICALS, INC. (Issuer) XU CHERYL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 2:33 PM | 60 Degrees Pharmaceuticals (Issuer) 60 DEGREES PHARMACEUTICALS, INC. (Issuer) DOW GEOFFREY S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2024 11:15 PM | 60 Degrees Pharmaceuticals (Filer) 60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form EFFECT | |
01/22/2024 4:01 PM | 60 Degrees Pharmaceuticals (Filer) 60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/16/2024 1:56 PM | 60 Degrees Pharmaceuticals (Filer) 60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2023 9:29 AM | 60 Degrees Pharmaceuticals (Subject) 60 DEGREES PHARMACEUTICALS, INC. (Subject) KNIGHT THERAPEUTICS INTERNATIONAL SA (Filed by)
| Form SC 13G | |
12/18/2023 8:23 AM | 60 Degrees Pharmaceuticals (Issuer) 60 DEGREES PHARMACEUTICALS, INC. (Issuer) Knight Therapeutics Inc (Reporting) KNIGHT THERAPEUTICS INTERNATIONAL SA (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/20/2023 11:41 AM | 60 Degrees Pharmaceuticals (Filer) 60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/15/2023 4:14 PM | 60 Degrees Pharmaceuticals (Filer) 60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form NT 10-Q | |
10/12/2023 3:17 PM | 60 Degrees Pharmaceuticals (Filer) 60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/18/2023 3:31 PM | 60 Degrees Pharmaceuticals (Filer) 60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/25/2023 2:26 PM | 60 Degrees Pharmaceuticals (Filer) 60 DEGREES PHARMACEUTICALS, INC. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |